News:
Positive Results Published on Clinical Trials of Oral FTY720 (Fingolimod) for Relapsing MS -- Novartis Applies to FDA and European Regulatory Agency for Approval
FDA Approves Fampridine SR, Now Called Ampyra,™ to Improve Walking for People with All Types of MS
Person treated with Tysabri for MS develops brain cancer
Panel Recommends that FDA Approve Fampridine-SR (proposed name Amaya) for Symptomatic Treatment of MS -- Found to improve walking speed for all types of MS